spacer
home > epc > autumn 2008 > lifecycle conundrum
PUBLICATIONS
European Pharmaceutical Contractor

Lifecycle Conundrum

The pharmaceutical industry has entered a period of evolution and the next five to 10 years are certainly set to be interesting. Undoubtedly these are challenging times for the traditional model of large pharmaceutical companies, where each have a handful of major blockbuster products which, in turn, help to propagate the next round of R&D, whilst also returning a healthy profit on investment. With the recent decline in pipeline products passing through Phase III trials, it is an ageing product portfolio which is sustaining R&D.

These older products are soon to be open to legitimate generic competition and concurrently there has been a large increase in the number of specialised and generic companies bringing products rapidly to market, increasing the level of competition in the sector. Counterbalanced against both branded and generic medicines has been the explosion in counterfeits flooding the market, aided by the global expansion of the internet and direct consumer marketing.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Claire Madden-Smith is the Commercial Director at Molecular Profiles, a CRO providing advanced analysis, consultancy and formulation support to the pharmaceutical and biopharmaceutical industry. Claire completed her PhD in Physical Chemistry in 1998 and joined Molecular Profiles in 2001, providing advanced analysis and testing for development, manufacturing and intellectual property issues. Claire has presented extensively around the globe on analysis and understanding of drug delivery systems and is currently the Chair of the Marketing Committee of the Controlled Release Society and a committee member of the Material Science Focus Group of the British Academy of Pharmaceutical Sciences.
spacer
Dr Claire Madden-Smith
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sartorius debuts the Intellicyt iQue3 at CYTO® 2019

Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3. The event – which takes place in Vancouver, Canada, from June 22 to 26 – will give delegates the chance to explore a smarter way to perform flow cytometry experiments.
More info >>

White Papers

How to Reduce Costs of Specialty Pharmaceutical Shipments and Increase Patient Satisfaction

Temptime Corporation

The specialty pharmacy industry could reduce costs by $27.5 million annually (product and call center staff costs only) if visual temperature indicators were used as decision-making tools to determine if medicine should be used or returned when patients suspect heat damage. In addition, 97% of patients surveyed, who received medicine from specialty pharmacies with a visual temperature indicator included in the package, agree that they would want an indicator in all shipments and 95% agree the indicator increased their confidence in the medicines received.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement